Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epidemic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
This document presents a consolidated summary of urgent activities
required to advance preparedness, as elaborated in each country's
national plan, with a particular focus on Priority 1 countries. It
presents the estimated requirements, needs, and gaps for each of the
Priority 1 countries and a summary for Priority 2 countries, as
aligned for the period of July to December 2019.
Eleven (11) districts in Rwanda were initially were considered most at risk of the outbreak, namely:
• Rusizi, Nyamasheke, Karongi, Rutsiro, Rubavu (bordering DRC)
• Musanze, Burera, Gicumbi and Nyagatare (bordering Uganda)
• Kigali city (comprised of 3 localities) due to the presence of Kigali International Airport.
The National Contingency plan was revised in February 2019 and two districts added to the list (Nyabihu and Nyanza), bring total districts at risk to 13. During the timeframe, the operation, however covered the 11 initial districts.
4ième edition (PSR-4)
Five Ebola alerts were reported from 19 – 25 July. Rapid response teams were deployed for case investigation and sample collection. GenXpert and Polymerase Chain Reaction (PCR) test results were negative for the two samples that met case definition.
The Hon. Minister for Health and WHO Representative made a press statement at South Sudan Broadcasting Cooperation (SSBC) to dispel rumors and misinformation circulating following an EVD alert reported in Juba that created lot of panic. A lot of rumors were generated on social media.
Two linked drills for National Rapid response team and case management teams were conducted in Juba on 26 July. The drills tested the functions of alert notification, Rapid Response Team activation, deployment, case investigation and transfer of a patient, triage and admission and isolation unit. The purpose of these simulation exercises were to the operational readiness of the RRT and the Case management team. Similar Drills will be conducted in Nimule, Yei, Maridi and Yambio in August
One hundred and eighty (180) frontline health workers were vaccinated against EVD in Yei River state. The cumulative number of front-line health care workers in South Sudan is 2,973.
Since the beginning of December a significant increase in the incidence of new cases has been observed particularly along the corridor towards the large urban center of Butembo (health zones of Butembo and Katwa) and beyond in the zone of Kayna health center located about 150 km from Goma. In addition, active outbreaks have emerged to the north, particularly in the health zones of Komanda and Oicha.
The third strategic response plan (SRP-3), which covers February through end July 2019, considers the salient points and recommendations made during the operational review of the implementation of the SRP-2 and other guidance based on lessons learned and risk analysis.